Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Adults with obesity receiving once-weekly semaglutide 7.2 mg lost a higher proportion of their body weight at 72 weeks than ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

Eli Lilly markets its tirzepatide medicines ... of semaglutide 7.2 mg for adults with T2D and obesity, in the next few months. In the past 30 days, Castle Biosciences’ earnings estimates ...

New research suggests that factors like age, sex, body fat and the amount of sugar in your blood play a significant role in the progression from pre-diabetes to a type 2 diabetes diagnosis.

Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular ...

Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand ...

(You are overweight if your BMI is greater than or equal to 25 and obese if your BMI is greater than or equal to 30 ... of tirzepatide, branded as KwikPen, with dosages between 2.5 mg and ...